Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.

Carvajal LA, Neriah DB, Senecal A, Benard L, Thiruthuvanathan V, Yatsenko T, Narayanagari SR, Wheat JC, Todorova TI, Mitchell K, Kenworthy C, Guerlavais V, Annis DA, Bartholdy B, Will B, Anampa JD, Mantzaris I, Aivado M, Singer RH, Coleman RA, Verma A, Steidl U.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaao3003. doi: 10.1126/scitranslmed.aao3003.

PMID:
29643228
2.

Oral uricase eliminates blood uric acid in the hyperuricemic pig model.

Szczurek P, Mosiichuk N, Woliński J, Yatsenko T, Grujic D, Lozinska L, Pieszka M, Święch E, Pierzynowski SG, Goncharova K.

PLoS One. 2017 Jun 8;12(6):e0179195. doi: 10.1371/journal.pone.0179195. eCollection 2017.

3.

Plasminogen fragments K 1-3 and K 5 bind to different sites in fibrin fragment DD.

Grinenko TV, Kapustianenko LG, Yatsenko TA, Yusova OI, Rybachuk VN.

Ukr Biochem J. 2016 May-Jun;88(3):36-45. doi: 10.15407/ubj88.03.036.

PMID:
29235323
4.

Effect of fibrin degradation products on fibrinolytic process.

Yatsenko TA, Rybachuk VM, Yusova OI, Kharchenko SM, Grinenko TV.

Ukr Biochem J. 2016 Mar-Apr;88(2):16-24. doi: 10.15407/ubj88.02.016.

PMID:
29227597

Supplemental Content

Loading ...
Support Center